Literature DB >> 22718846

Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases.

Norman J Carr1, Jenny Finch, Ian Charles Ilesley, Kandiah Chandrakumaran, Faheez Mohamed, Alex Mirnezami, Tom Cecil, Brendan Moran.   

Abstract

AIMS: The classification of abdominal mucinous neoplasia is a controversial area. In 2010, WHO published a classification which divides pseudomyxoma peritonei (PMP) into low and high grades. The aim of the authors was to correlate this classification with the prognosis and site of primary neoplasm.
METHODS: The authors reviewed 274 patients with PMP who had undergone surgery at a single institution and classified them according to WHO criteria. The findings were correlated with clinical information and survival data.
RESULTS: PMP was low grade in 78% of patients and high grade in 22%. The appendix accounted for 94% of lesions, and the most common primary tumour was a low grade appendiceal mucinous neoplasm. Colorectal primaries were more likely to be associated with high grade PMP. There was an excellent correlation between the grade of the PMP and the primary neoplasm; only two cases showed discordant morphology: both were high grade appendiceal adenocarcinomas that were associated with low grade PMP. Nodal metastases were more likely in high grade lesions, but there was no significant difference in the rate of parenchymal organ invasion between low grade and high grade. Low grade morphology was associated with significantly longer survival than high grade (overall 5-year survival of 63% for low grade and 23% for high grade).
CONCLUSIONS: Categorisation as either low grade or high grade by WHO criteria correlates with prognosis. The grade of the PMP is generally consistent with the grade of the primary neoplasm. Colorectal primaries are more likely to be associated with high grade PMP.

Entities:  

Mesh:

Year:  2012        PMID: 22718846     DOI: 10.1136/jclinpath-2012-200843

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Philipp Horvath; Can Yurttas; Philipp Birk; Florian Struller; Alfred Königsrainer
Journal:  Langenbecks Arch Surg       Date:  2018-12-01       Impact factor: 3.445

2.  Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique.

Authors:  Rebecca Fish; Chelliah Selvasekar; Peter Crichton; Malcolm Wilson; Paul Fulford; Andrew Renehan; Sarah O'Dwyer
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

3.  In reply.

Authors:  Dario Baratti; Shigeki Kusamura; Claudia Maggi; Filippo de Braud; Marcello Deraco; Maria Di Bartolomeo; Filippo Pietrantonio
Journal:  Oncologist       Date:  2015-03

4.  Pseudomyxoma peritonei originating from urachus-case report and review of the literature.

Authors:  A K Agrawal; P Bobiński; Z Grzebieniak; J Rudnicki; G Marek; P Kobielak; M Kazanowski; S Agrawal; A Hałoń
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

5.  Appendicitis mimicking the CT appearance of an appendiceal mucinous neoplasm.

Authors:  Jia Qi Jeremy Soon; Syed Aftab; Lianne Lee Ai Ling; Srinivas Anand Swaroop Uppaluri; Shi Xian Shawn Kok
Journal:  J Radiol Case Rep       Date:  2020-11-30

6.  Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.

Authors:  Ryuma Tokunaga; Joanne Xiu; Curtis Johnston; Richard M Goldberg; Philip A Philip; Andreas Seeber; Madiha Naseem; Jae Ho Lo; Hiroyuki Arai; Francesca Battaglin; Alberto Puccini; Martin D Berger; Shivani Soni; Wu Zhang; Jimmy J Hwang; Anthony F Shields; John L Marshall; Hideo Baba; W Michael Korn; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2019-01-28       Impact factor: 12.531

7.  Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.

Authors:  Lilli Saarinen; Pirjo Nummela; Hannele Leinonen; Annamari Heiskanen; Alexandra Thiel; Caj Haglund; Anna Lepistö; Tero Satomaa; Sampsa Hautaniemi; Ari Ristimäki
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

8.  Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  Alvaro Arjona-Sanchez; Francisco Cristobal Muñoz-Casares; Angela Casado-Adam; Juan Manuel Sánchez-Hidalgo; Maria Dolores Ayllon Teran; Rafael Orti-Rodriguez; Ana Cristina Padial-Aguado; Javier Medina-Fernández; Rosa Ortega-Salas; Gema Pulido-Cortijo; Auxiliadora Gómez-España; Sebastián Rufián-Peña
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  "The Jelly Belly": Diagnostic Dilemmas and Current Concepts.

Authors:  Priyanka Punit Kedia; Gayatri Ravikumar; Suravi Mohanty; Julian Crasta; Elizabeth Vallikad
Journal:  J Obstet Gynaecol India       Date:  2016-07-01

Review 10.  Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei.

Authors:  Veena Ramaswamy
Journal:  Indian J Surg Oncol       Date:  2016-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.